SBF2 and cancer: SBF2-AS1 is upregulated in esophageal squamous cell carcinoma (ESCC), cervical cancer (CC), hepatocellular carcinoma (HCC), and osteosarcoma (OS) to promote the development of cancer, and its expression is associated with poor prognosis [7–10].